Medicine

Projects

Projects per year 1975 1989 2002 2005 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2021 2025

• 25 Not started
• 174 Active
• 747 Finished

Projects per year

Search results

• Women's Interagency HIV Study (WIHS-V)

  Anastos, K. & Sharma, A.

  National Institute of Allergy and Infectious Diseases

  8/1/93 → 12/31/19

  Project: Research project

  • HIV 100%
  • HIV Infections 46%
  • Genitalia 27%
  • Virology 24%
  • Highly Active Antiretroviral Therapy 11%

• WILSON'S DISEASE AND COPPER METABOLISM

  Karen, G., Cohen, B., Lynn, R., Nitowsky, H., Bash, R., Barth, R., Deming, Q., Halbreich, U., Hein, K., Saenger, P., Sherwood, L., Kaplan, B., Portenoy, R., Dutcher, J., Rubinstein, A., Billett, H., Shim, C., Vogl, S., Asnis, G., Eder, H., Mitchell, Y., Ferraru, E., Crystal, H., Engel, S., Wolfson, L., Wolfson, L., Gilbert, H., Thal, L., Stein, H. D., Romney, S., Nagel, R., Wylie-Rosett, J., Blechman, E., Nagel, R., Nieberger, R., Appel, D., Aronson, M., Simon, D., Freeman, R., Wiernik, P., Fleischer, N., Scheinberg, I. H., Brown, S., Soeiro, R. U. Y., Rubinstein, A., Mazze, R., Edelmann, C., Romney, S., Keefe, D., Rubin, D., Bornstein, M., Fotino, S., Purpura, D., Nitowsky, H., Bash, R., Barth, R., Halbreich, U., Sherwood, L., Portenoy, R., Dutcher, J., Billett, H., Shim, C., Crystal, H., Engel, S., Wolfson, L., Stein, H. D., Nagel, R., Nieberger, R., Appel, D., Aronson, M., Scheinberg, I. H., Soeiro, R. U. Y., Romney, S., Keefe, D., Fotino, S. & Billett, H. H.

  1/1/01 → 3/31/91

  Project: Research project

  • Hepatolenticular Degeneration 100%
  • Copper 25%
  • Laparotomy 23%
  • Biopsy 15%
  • Liver 13%

• Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53

  Zhao, H. & Schwartz, E. L.

  4/12/19 → 3/31/22

  Project: Research project

  • Small Cell Lung Carcinoma 100%
  • Drug Therapy 17%
  • Heterografts 16%
  • Ubiquitination 13%
  • Neoplasms 11%

• Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53

  Schwartz, E. L. & Zhao, H.

  National Cancer Institute

  4/12/19 → 3/31/22

  Project: Research project

  • Small Cell Lung Carcinoma 100%
  • Drug Therapy 18%
  • Heterografts 16%
  • Ubiquitination 13%
  • Neoplasms 12%

• Vitamin D3 and Intestinal Tumorigenesis

  Augenlicht, L. H. & Rose, S. A.

  12/1/09 → 11/30/12

  Project: Research project

  • Cholecalciferol 100%
  • Macrophages 44%
  • Epithelial Cells 41%
  • Neoplasms 20%
  • Colonic Neoplasms 15%

• Vitamin D3 and Intestinal Tumorigenesis

  Augenlicht, L. H.

  National Cancer Institute

  12/1/09 → 11/30/12

  Project: Research project

  • Cholecalciferol 100%
  • Macrophages 46%
  • Carcinogenesis 45%
  • Epithelial Cells 43%
  • Neoplasms 21%

• Viral Immunoregulatory Genes and Hepatocyte Transplants

  Roy-Chowdhury, J.

  National Institute of Diabetes and Digestive and Kidney Diseases

  2/1/05 → 1/31/10

  Project: Research project

  • Viral Genes 100%
  • Hepatocytes 87%
  • Adenoviridae 70%
  • Transplants 53%
  • Liver 21%

• VEGF INDUCED SIGNAL TRANSDUCTION

  Sibinga, N. E. S., Terman, B., Rose, S. A. & Rose, S. A.

  8/16/99 → 4/30/10

  Project: Research project

  • Vascular Endothelial Growth Factor A 100%
  • Signal Transduction 90%
  • Neoplasms 87%
  • Nutrients 65%
  • Endothelial Cells 57%

• VEGF Induced Signal Transduction

  Terman, B. & Sibinga, N. E. S.

  National Cancer Institute

  8/16/99 → 4/30/10

  Project: Research project

  • Vascular Endothelial Growth Factor A 100%
  • Signal Transduction 74%
  • Cell Proliferation 37%
  • Reactive Oxygen Species 22%
  • Non-Receptor Type 6 Protein Tyrosine Phosphatase 22%

• VARIABLE GENE USE AND PNEUMOCOCCAL IMMUNITY IN AIDS

  Pirofski, L. & Rose, S. A.

  7/1/00 → 1/31/12

  Project: Research project

  • Streptococcus pneumoniae 100%
  • Antibodies 66%
  • HIV 60%
  • HIV Infections 48%
  • Epitopes 46%

• Variable Gene Use and Pneumococcal Immunity in AIDS

  Pirofski, L.

  National Institute of Allergy and Infectious Diseases

  7/1/00 → 1/31/12

  Project: Research project

  • Acquired Immunodeficiency Syndrome 100%
  • Immunity 97%
  • Vaccines 73%
  • Streptococcus pneumoniae 64%
  • Genes 48%

• VARIABLE GENE DEFECTS AND PNEUMOCOCCAL SUSCEPTIBILITY

  Pirofski, L. & Rose, S. A.

  4/1/01 → 4/30/12

  Project: Research project

  • Polysaccharides 100%
  • Pneumococcal Infections 58%
  • Pneumococcal Vaccines 44%
  • Molecular Structure 42%
  • Antibodies 32%

• Variable Gene Defects and Pneumococcal Susceptibility

  Pirofski, L.

  National Institute of Allergy and Infectious Diseases

  4/1/01 → 4/30/12

  Project: Research project

  • Pneumococcal Vaccines 100%
  • Polysaccharides 89%
  • Pneumococcal Infections 74%
  • Antibodies 63%
  • Streptococcus pneumoniae 57%

• Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients

  Nahvi, S.

  NATIONAL INSTITUTE ON DRUG ABUSE

  9/21/10 → 8/31/16

  Project: Research project

  • Varenicline 100%
  • Methadone 84%
  • Withholding Treatment 77%
  • Smoking Cessation 72%
  • Directly Observed Therapy 54%

• Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients

  Nahvi, S.

  9/21/10 → 8/31/16

  Project: Research project

  • Methadone 100%
  • Smoking Cessation 87%
  • Directly Observed Therapy 53%
  • Varenicline 51%
  • Smokers 36%

• VANADIUM SALTS AND CARBOHYDRATE METABOLISM

  Shamoon, H.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/30/93 → 9/29/98

  Project: Research project

  • Glucose 100%
  • Pharmacological Metabolism 61%
  • Carbohydrate 60%
  • Glycogen 54%
  • Insulin Derivative 34%

• VANADIUM SALTS AND CARBOHYDRATE METABOLISM

  Shamoon, H. & Rossetti, L.

  9/30/93 → 9/29/98

  Project: Research project

  • Glucose 100%
  • Glycogen 54%
  • Insulin Derivative 34%
  • Pharmacological Metabolism 17%
  • Pyruvate 11%

• Utilizing Innovative Technology To Improve Compliance With Patient Elevation Guidelines ? The Impact Of Angulus On Adherence To The Evidence-Based VAP-Prevention Bundle

  Gong, M. N.

  9/2/16 → 4/30/19

  Project: Research project

  • Ventilator-Associated Pneumonia 100%
  • Guidelines 43%
  • Critical Care 39%
  • Patient Compliance 32%
  • National Heart, Lung, and Blood Institute (U.S.) 15%

• Utilizing Innovative Technology To Improve Compliance With Patient Elevation Guidelines ? The Impact Of Angulus On Adherence To The Evidence-Based VAP-Prevention Bundle

  GAMARNIK, V. & Gong, M. N.

  National Heart, Lung, and Blood Institute

  9/2/16 → 4/30/19

  Project: Research project

  • Ventilator-Associated Pneumonia 100%
  • Patient Compliance 63%
  • Guidelines 48%
  • Technology 40%
  • Critical Care 22%

• Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia

  George, C. J.

  9/15/20 → 5/31/22

  Project: Research project

  • Cognitive Dysfunction 100%
  • Angiotensin-Converting Enzyme Inhibitors 85%
  • Gait 66%
  • Retirement 41%
  • Organized Financing 41%

• Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia

  George, C. J.

  National Institute on Aging

  6/1/21 → 5/31/22

  Project: Research project

  • Angiotensin-Converting Enzyme Inhibitors 100%
  • Cognitive Dysfunction 96%
  • Gait 64%
  • Dementia 63%
  • Retirement 40%

• Using a Social-Ecological Framework to Support Community Health Research

  Hernandez, P. & Walker, E. A.

  National Institute on Minority Health and Health Disparities

  7/6/10 → 9/30/13

  Project: Research project

  • Urban Health 100%
  • Public Health 64%
  • Health 47%
  • Data Management 21%
  • Organizations 13%

• Using a Social-Ecological Framework to Support Community Health Research

  Hernandez, P. & Walker, E. A.

  7/6/10 → 9/30/13

  Project: Research project

  • Urban Health 100%
  • Health 47%
  • Public Health 40%
  • Data Management 21%
  • Organizations 13%

• Understanding the molecular regulation of autophagy during aging

  Singh, R.

  National Institute on Aging

  9/1/17 → 5/31/20

  Project: Research project

  • Autophagy 100%
  • Light 77%
  • Messenger RNA 34%
  • Autophagy-Related Proteins 31%
  • Autophagosomes 26%

• Understanding the molecular regulation of autophagy during aging

  Singh, R.

  9/1/17 → 5/31/20

  Project: Research project

  • Autophagy 100%
  • Light 91%
  • Messenger RNA 40%
  • Autophagy-Related Proteins 37%
  • Autophagosomes 31%

• TRIIODOTHYRONINE RECEPTORS AND NONTHYROIDAL DISEASES

  Surks, M. I.

  12/31/89 → 6/30/91

  Project: Research project

  • triiodothyronine 100%
  • receptors 64%
  • phenytoin 44%
  • carcinoma 33%
  • rats 27%

• TRH RECEPTOR CLONING

  Pessin, J. E.

  12/31/89 → 6/30/04

  Project: Research project

• TREATMENT OF MALIGNANT PLEURAL EFFUSIONS

  Perez-Soler, R.

  9/30/92 → 9/29/95

  Project: Research project

  • bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II) 100%
  • Liposomes 35%
  • Malignant Pleural Effusion 35%
  • Pleural Cavity 20%
  • Lymph Nodes 14%

• TREAT ECARDS: Translating Evidence into Action: Electronic Clinical Decision Support in ARDS

  Gong, M. N.

  9/1/18 → 6/30/21

  Project: Research project

  • Adult Respiratory Distress Syndrome 100%
  • Clinical Decision Support Systems 28%
  • Practice Guidelines 12%
  • Professional Practice 10%
  • Workflow 9%

• Treat All and beyond: addressing methods, data and capacity building challenges in the African regions of IeDEA

  Anastos, K.

  8/1/19 → 7/31/20

  Project: Research project

  • Capacity Building 100%
  • Africa South of the Sahara 82%
  • Research Personnel 78%
  • National Institute of Allergy and Infectious Diseases (U.S.) 57%
  • Rwanda 54%

• Treat All and beyond: addressing methods, data and capacity building challenges in the African regions of IeDEA

  Anastos, K. & Davies, M. A.

  National Institute of Allergy and Infectious Diseases

  8/1/19 → 7/31/20

  Project: Research project

  • Capacity Building 100%
  • Africa South of the Sahara 30%
  • Research Personnel 28%
  • National Institute of Allergy and Infectious Diseases (U.S.) 21%
  • Rwanda 19%

• Transplantation of Endothelial Cells

  Gupta, S.

  4/1/05 → 4/30/19

  Project: Research project

  • Endothelial Cells 100%
  • Liver 58%
  • Transplantation 25%
  • Cell- and Tissue-Based Therapy 21%
  • Cell Biology 19%

• Transplantation of Endothelial Cells

  Gupta, S.

  National Institute of Diabetes and Digestive and Kidney Diseases

  4/1/06 → 4/30/19

  Project: Research project

  • Endothelial Cells 100%
  • Transplantation 95%
  • Liver 68%
  • Cell- and Tissue-Based Therapy 40%
  • Endothelial Progenitor Cells 19%

• TRANSMEMBRANE ACTIVATION OF THE INSULIN RECEPTOR KINASE

  Pessin, J. E. & Pessin, J. E.

  12/31/89 → 6/30/93

  Project: Research project

  • Insulin Receptor 100%
  • Protein Kinases 71%
  • Insulin 45%
  • Adenosine Triphosphate 43%
  • Binding Sites 25%

• Translating the Diabetes Prevention Program to Engage Men in Disadvantaged Areas

  Walker, E. A.

  National Institute of Diabetes and Digestive and Kidney Diseases

  8/15/14 → 7/31/18

  Project: Research project

  • Vulnerable Populations 100%
  • Population Groups 99%
  • Centers for Disease Control and Prevention (U.S.) 98%
  • Epidemics 82%
  • Weight Loss 79%

• Translating the Diabetes Prevention Program to Engage Men in Disadvantaged Areas

  Walker, E. A.

  8/15/14 → 7/31/15

  Project: Research project

  • Vulnerable Populations 100%
  • Population Groups 99%
  • Centers for Disease Control and Prevention (U.S.) 98%
  • Epidemics 82%
  • Weight Loss 79%

• Transcriptional regulation of hematopoietic stem cell fate during aging and bone marrow failure

  Will, B.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/22/15 → 7/31/20

  Project: Research project

  • Bone Marrow Failure Disorders 100%
  • Hematopoietic Stem Cells 76%
  • Cytosine 20%
  • Cellular Senescence 18%
  • DNA Methylation 16%

• Transcriptional regulation of hematopoietic stem cell fate during aging and bone marrow failure

  Will, B.

  9/22/15 → 7/31/20

  Project: Research project

  • Hematopoietic Stem Cells 100%
  • Cytosine 60%
  • Cellular Senescence 55%
  • DNA Methylation 49%
  • Cell Biology 43%

• Trajectories and modifiable risk factors of brain, gait, and cognitive decline in aging and pre-dementia

  Blumen, H. M.

  National Institute on Aging

  4/1/21 → 3/31/22

  Project: Research project

  • Gait 100%
  • Dementia 69%
  • Cognitive Dysfunction 67%
  • Brain 42%
  • Social Networking 30%

• Trajectories and modifiable risk factors of brain, gait, and cognitive decline in aging and pre-dementia

  Blumen, H. M.

  6/15/20 → 3/31/22

  Project: Research project

  • Gait 100%
  • Dementia 51%
  • Cognitive Dysfunction 50%
  • Brain 34%
  • Social Networking 29%

• Training in Cancer Therapeutics Research

  Chu, E.

  9/25/15 → 8/31/21

  Project: Research project

  • Neoplasms 100%
  • Medical Oncology 86%
  • Therapeutic Human Experimentation 74%
  • Mentors 68%
  • Translational Medical Research 61%

• Training in Cancer Therapeutics Research

  Chu, E.

  National Cancer Institute

  9/25/15 → 8/31/21

  Project: Research project

  • Therapeutic Human Experimentation 100%
  • Neoplasms 29%
  • Medical Oncology 27%
  • Mentors 21%
  • Translational Medical Research 19%

• Training in Aging Research

  Barzilai, N. & Rossetti, L.

  National Institute on Aging

  5/1/04 → 4/30/22

  Project: Research project

  • trainee 100%
  • Longevity 98%
  • biology 95%
  • Autophagy 52%
  • grant 43%

• Training in Aging Research

  Barzilai, N., Rossetti, L., Rose, S. A., Rose, S. A. & Rose, S. A.

  5/1/04 → 4/30/22

  Project: Research project

  • species recruitment 100%
  • women's health 96%
  • mentoring 86%
  • metabolic syndrome 76%
  • menopause 74%

• TOXOPLASMA RIBONUCLEOTIDE REDUCTASE AS A DRUG TARGET

  Kim, K. & Taubenberger, J.

  7/1/93 → 6/30/96

  Project: Research project

  • ribonucleotide reductase 100%
  • toxoplasmosis 46%
  • Toxoplasma 36%
  • Toxoplasma gondii 20%
  • enzymes 19%

• Toxoplasma Epigenomics and Gene Expression

  Kim, K.

  3/15/10 → 2/29/16

  Project: Research project

  • Toxoplasma gondii 100%
  • bradyzoites 58%
  • gene expression 35%
  • transcription factors 30%
  • epigenetics 28%

• Toxoplasma Epigenomics and Gene Expression

  Kim, K.

  National Institute of Allergy and Infectious Diseases

  3/15/10 → 2/29/16

  Project: Research project

  • Toxoplasma 100%
  • Toxoplasma gondii 95%
  • epigenetics 76%
  • bradyzoites 60%
  • gene expression 48%

• TOXOPLASMA DEVELOPMENT AND CELL CYCLE

  Kim, K.

  4/1/98 → 3/31/03

  Project: Research project

  • cell cycle 100%
  • bradyzoites 79%
  • Toxoplasma gondii 68%
  • Toxoplasma 60%
  • tachyzoites 50%

• TNF-like weak inducer of apoptosis (TWEAK) signaling in lupus nephritis

  Putterman, C.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/1/11 → 8/31/15

  Project: Research project

  • Lupus Nephritis 100%
  • Apoptosis 43%
  • Kidney 40%
  • Podocytes 36%
  • TWEAK Receptor 35%

• TNF-like weak inducer of apoptosis (TWEAK) signaling: a novel therapeutic target

  Putterman, C.

  9/1/11 → 8/31/15

  Project: Research project

  • Lupus Nephritis 100%
  • Kidney 55%
  • Podocytes 37%
  • TWEAK Receptor 36%
  • Cytokines 31%